Latest News

Geopolitics, new regulations, and a stronger policy push into sustainable investments are reshaping where risks and opportunities sit in the market. With energy routes under pressure and governments aiming to support vulnerable industries and market stability, investors are looking for companies that combine scale, resilience, and exposure to long term sustainability themes. This article uses a Sustainable Investments screener focused on larger companies in clean energy, infrastructure, and...

In late June 2026, Harley-Davidson, Inc. was reclassified across multiple FTSE Russell indices, moving from the Russell 1000 and Midcap families into the Russell 2000, including value and defensive variants, while also announcing the departure of Chief Legal, Compliance and Corporate Affairs Officer Paul Krause and the appointment of successor Gayle Littleton. This reshuffling alters which index-tracking funds hold Harley-Davidson and may influence how investors view the company’s size...

McKesson (MCK) stock has been in focus after a recent 2.09% decline, as investors weighed softer quarterly results against index additions, expanded partnerships and the company’s continued tilt toward higher margin healthcare segments. See our latest analysis for McKesson. Over the past year, McKesson’s share price return has been mixed. A recent 4.52% one-month gain contrasts with a 13.14% decline over three months and a 6.73% fall year to date. Total shareholder return over 1, 3 and 5...

In recent days, EVERTEC has attracted renewed attention as one of Latin America's leading payment processors, with analysts highlighting its strong cash generation, solid annual revenue growth and earnings expansion outpacing peers, underpinned by its ATH debit network across Latin America and the Caribbean. An important angle for investors is EVERTEC's high return on equity, which points to effective capital allocation and management discipline in scaling its payments infrastructure across...

In recent days, Digital Turbine announced the sale of select AdColony assets to Affle MEA FZ and introduced Launchpad, a unified app distribution platform aimed at simplifying deployments across carriers and device makers. Together, the asset sale and Launchpad rollout signal a sharper focus on core media and distribution capabilities, potentially streamlining Digital Turbine’s technology stack and clarifying how it creates value for app developers and partners. We’ll now examine how...

Recently, ePlus highlighted an independent VistaXM survey showing it achieved a Net Promoter Score of 74, well above typical technology industry averages, alongside being named Everpure’s Services Partner of the Year for its Storage-as-a-Service offering. Together, these strong customer satisfaction metrics and partner recognition underscore how ePlus’s focus on customer experience and innovative service models is resonating with its client base. We’ll now examine how this exceptionally high...

China Galaxy Securities (SEHK:6881) has drawn investor attention after its 2025 Annual General Meeting approved a final cash dividend. The ex-dividend, record and payment dates are now set for July and August 2026. See our latest analysis for China Galaxy Securities. The share price of China Galaxy Securities has come under pressure recently, with a year to date share price return down 28.95% and a 30 day share price return down 6.68%, even though the 3 year total shareholder return is up...

Valero Energy (VLO) moved firmly into the large cap arena after being added to several Russell Top 200 and growth benchmarks, while exiting certain mid cap indexes on June 27, 2026. See our latest analysis for Valero Energy. The index reshuffle comes on the back of strong trading interest in Valero Energy, with a 1-day share price return of 3.46% and a 7-day share price return of 11.14%, while the 1-year total shareholder return of 94.52% and 5-year total shareholder return of 339.56%...

NEC (TSE:6701) is back in focus after Japan selected the company for a government backed AI consortium that could receive up to $6.1b in funding for foundation model development and related projects. See our latest analysis for NEC. The AI consortium announcement comes after a mixed period for NEC, with the share price up 5.40% in the last day and 11.68% over seven days, yet down 22.78% year to date. Over the longer term, total shareholder returns over three and five years have been very...

What RS Technologies' Grid Battery Move Means for Shareholders RS Technologies (TSE:3445) has approved participation in a 99.82 MW, roughly 400 MWh grid-scale battery energy storage project in Tochigi Prefecture, committing funding through a special purpose company silent partnership. The project, scheduled to start operations in October 2029, is designed to support electricity supply and demand balancing as renewable energy use expands. It may also create an additional potential earnings...

Recent coverage has highlighted that Strategic Education’s earnings outlook has improved and that analysts currently view the company as offering relatively attractive value compared with a close peer in the schools sector. This shift in analyst sentiment comes despite earlier concerns about flat domestic student numbers, pressure on per‑share profitability, and expectations for softer cash flow margins. We’ll now examine how this improving analyst sentiment, despite enrollment and...

Artificial intelligence is moving from buzzword to budget line item, and Microsoft’s new US$2.5b Frontier Co unit shows how quickly that shift can affect listed stocks. With 6,000 Microsoft employees now assigned to hands on AI implementation, investors are rethinking which companies could gain from faster adoption and which might face tougher competition or higher expectations. This article looks at 3 stocks from the AI Adoption Leaders screener that are directly exposed to this news and...

In June 2026, NeoGenomics, Inc. announced it had appointed Carolyn Starrett, former Flatiron Health CEO and experienced healthcare data and AI leader, to its Board of Directors. Her background in applying AI and real-world data to cancer care and drug development could meaningfully influence how NeoGenomics develops and commercializes its oncology testing and digital solutions. We’ll now examine how Starrett’s AI and data-driven oncology expertise may influence NeoGenomics’ existing...

Aramark (ARMK) has drawn fresh attention after being added to the Russell 1000 Defensive and Russell 1000 Value Defensive indices, a move that reflects institutional interest in the stock. See our latest analysis for Aramark. Those index additions come after a strong run in Aramark’s share price, with a 90 day share price return of 31.84% and year to date share price return of 53.36%, alongside a 5 year total shareholder return of 129.43%. This suggests momentum has been firm over both short...

BeOne Medicines recently reported positive topline Phase 3 MANGROVE results showing its BTK inhibitor BRUKINSA plus rituximab improved progression-free survival over bendamustine plus rituximab in previously untreated mantle cell lymphoma, using a chemotherapy-free, rituximab maintenance-free regimen. This is the first global Phase 3 trial to test a fully chemotherapy-free BTK inhibitor regimen as initial treatment in mantle cell lymphoma, potentially sparing patients around two years of...

On 27 June 2026, Graham Corporation (NYSE:GHM) was added to both the Russell 2000 Growth-Defensive Index and the Russell 2000 Defensive Index, increasing its prominence among small-cap industrial names. This dual index inclusion comes as Graham reports strong fundamentals and record backlog tied to mission-critical heat-transfer and data center cooling equipment, potentially broadening its institutional investor base. Next, we’ll examine how this index inclusion, alongside record backlog in...

Some PACS Group, Inc. ( NYSE:PACS ) shareholders may be a little concerned to see that the Chief Accounting Officer...

Some Immunovant, Inc. ( NASDAQ:IMVT ) shareholders may be a little concerned to see that the Chief Technology Officer...

GoFintech Quantum Innovation (SEHK:290) has put fresh numbers on the table for FY 2026, with first half revenue of HK$1.0b and basic EPS of HK$0.029 setting the tone for how the year is shaping up. The company has seen revenue move from HK$21.3m in the first half of 2025 to HK$838.9m in the second half of 2025 and then to HK$1.0b in the first half of 2026. Basic EPS has shifted from a loss of HK$0.0017 to a small profit of HK$0.0012 and then HK$0.029 across the same periods, giving investors...

TGS (OB:TGS) stock is back in focus after the company and SLB announced the Pelotas Sul Phase 1 multi-client 3D seismic survey offshore Brazil, a large-scale project covering approximately 13,500 square kilometers. See our latest analysis for TGS. TGS shares trade at NOK129.7 after a 1 day share price return of 0.62%. Despite the 30 day share price return being down 15.56%, year to date the share price return is up 37.98% with a 1 year total shareholder return of 54.44%. This suggests...

In recent days, Range Resources, a US natural gas producer, saw investor attention increase after U.S. natural gas futures rose on forecasts for a heatwave, strong demand, and higher European gas prices supported by solid LNG export activity. This shift in the underlying commodity backdrop is important for Range because natural gas pricing directly feeds into its revenues and cash generation. We’ll now examine how stronger natural gas futures linked to heat-driven demand and LNG exports...

In late June 2026, Spyre Therapeutics filed a US$500 million at-the-market follow-on equity offering and an omnibus shelf registration covering common stock, preferred stock, debt, warrants, and units. Around the same time, the company was removed from several Russell Value indexes, a shift that can affect index-linked institutional ownership and trading flows. We’ll explore how Spyre Therapeutics’ large at-the-market equity program shapes its investment narrative and the potential...

Index removal puts Corcept Therapeutics in focus Corcept Therapeutics (CORT) was recently removed from both the Russell 1000 Defensive Index and the Russell 1000 Growth-Defensive Index, an adjustment that can prompt trading shifts by index-tracking funds. For existing and prospective shareholders, the move raises practical questions about how index-related flows might interact with Corcept Therapeutics’ current valuation, trading liquidity, and the company’s broader profile in the...

ACI Worldwide (ACIW) stock moved following reports of strong demand across its payment software portfolio, including issuing, acquiring, and real-time payment solutions, along with growth in its Biller segment and continued product development. See our latest analysis for ACI Worldwide. The recent news around strong demand in ACI Worldwide's payment software appears to align with building momentum in the stock, reflected in a 27.10% 90 day share price return and a 128.19% three year total...